Medicor Cancer Centre’s ‘No-Wait’ Philosophy

MEDICOR's Comments - Latest DCA Research Shows Favorable Results in Glioblastoma
May 31, 2010

Since the first paper on DCA as a potential cancer treatment was published in Cancer Cell in January 2007, there has been a great interest in further DCA research in humans.

Click to read more...

Case Study •
Glioblastoma Multiforme

A 42 year old male requested telemedicine consultation for treatment of glioblastoma. He developed unremitting headaches was diagnosed with a grade...

Click to view this case study

Case Study •
Metastatic Ovarian Carcinoma

A 59 year old female presented to us for treatment of metastatic ovarian carcinoma. The patient was diagnosed 4 years previously when she felt an axillary mass...

Click to view this case study

News Article • May 25th, 2009

Television interview with 2 patients in Norway

Click here to view interview
Click here to view PDF

LDN Research Trust Cancer Article •
February, 2009

The Role of Low Dose Naltrexone (LDN) in Cancer Treatment.

Click here to view PDF

Vesteralen Online Article •
December 11th, 2008

Medisinen er for billig - Legen som behandler den kreftsyke Geir Arne Ovaldsen mener årsaken til at medisinen ikke godkjennes, er at den er for billig.

Click here to view PDF

Canada’s first integrated private cancer treatment clinic.